D-0288-2015 Class III Terminated

Recalled by Sandoz, Inc — Princeton, NJ

FDA drug recall D-0288-2015 was initiated by Sandoz, Inc on Oct 2, 2014 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: An Out of Specification (OOS) result was generated for the 18 month stability time point for ketone cilexetil impurity and total impurities. The recall status is terminated (terminated Jul 23, 2015). Affected quantity: 6,336 bottles.

Recall details

Product Type
Drugs
Report Date
Dec 10, 2014
Initiation Date
Oct 2, 2014
Termination Date
Jul 23, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
6,336 bottles

Product description

candesartan cilexetil, tablets, 16 mg, 90-count bottles, Rx only, Manufactured for Sandoz Inc., Princeton, NJ 08540 by Mylan Laboratories Limited Hyderabad, 500 034, India, NDC 0781-5938-92

Reason for recall

Failed Impurities/Degradation Specifications: An Out of Specification (OOS) result was generated for the 18 month stability time point for ketone cilexetil impurity and total impurities.

Distribution pattern

Nationwide

Code information

Lot #: 3007330, Exp 11/2014

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0288-2015
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0288-2015. Report a data issue: hello@regdatalab.com.